Results 151 to 160 of about 57,342 (256)

Comparing Outcomes of Heartmate 3 and Heart Transplantation in Older Children With Dilated Cardiomyopathy—Can Transplantation be Delayed or Avoided?

Pediatric Transplantation, Volume 30, Issue 6, June 2026.
Adolescents with dilated cardiomyopathy treated with either HM3 or transplant had excellent 3‐year outcomes, though many HM3 pediatric patients are transplanted early after device placement. Further study is needed because longer‐term HM3 support has implications for delaying/avoiding transplantation, longer‐term patient survival, and donor organ ...
Waldemar F. Carlo, Luz A. Padilla, James K. Kirklin, Ryan S. Cantor, Devin Koehl, Jeffrey P. Jacobs, Shahnawaz Amdani, Kathryn Chatfield, Manan Desai, Gabrielle Vaughn, Catherine M. Montgomery, Katerina Boucek, Katheryn Gambetta, David L. S. Morales   +13 more
wiley   +1 more source

Phenotyping hemodynamic response to veno‐arterial extracorporeal membrane oxygenation in cardiogenic shock

Physiological Reports, Volume 14, Issue 11, June 2026.
Abstract Simulation models suggest that veno‐arterial extracorporeal membrane oxygenation (VA ECMO) uniformly results in left ventricular (LV) distension in cardiogenic shock (CS). This study characterized the hemodynamic response to VA ECMO in animal models of CS, and in patients with CS.
Hoong Sern Lim, Dagmar Vondrakova, Mikulas Micek, Petr Ostadal   +3 more
wiley   +1 more source

oXiris in severe cardiogenic shock with endotoxemia: interpreting the negative findings of the CLEAN-ECMO trial. [PDF]

Crit Care
Honoré PM, Benkaddour Y, De Lissnyder N, Khouja RB, Muscato CY.   +4 more
europepmc   +1 more source

Palliative and End-of-Life Care Utilization in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Population-Based Study. [PDF]

JACC Adv
Sterling LH, Fernando SM, Talarico R, Qureshi D, Di Santo P, van Diepen S, Herridge MS, Price S, Brodie D, Fan E, Needham DM, Scales DC, Combes A, Slutsky AS, Thiele H, Hibbert B, Tanuseputro P, Mathew R.   +17 more
europepmc   +1 more source

Fulminant flecainide intoxication in an adolescent: cardiogenic shock requiring VA-ECMO support. [PDF]

BMJ Case Rep
Kovacevic M, Bešenji I, Jarakovic M, Radonjic J, Stefanovic M, Crnomarkovic B, Keca S, Dimic S, Bjelica S, Srdanovic I.   +9 more
europepmc   +1 more source

Understanding Cardiogenic Shock [PDF]

European Journal of Heart Failure, 2015
openaire   +4 more sources

Heart Failure Wired from Shock to Devices and Home: A New Era of Delivery. [PDF]

US Cardiol
Yehya A, Echols MR.
europepmc   +1 more source

The Hong Kong Registry for Percutaneous Ventricular Assist Device. [PDF]

JACC Asia
Sung JG, So KC, Tam FC, Leung C, Chan JC, Cheuk CM, Shek J, Shek KP, Leung RW, Pong HT, Chan K, Fong MC, Fan KW, Wong JH, Fong EY, Wong CH, Fung RC, Chung TS, Wong CW, Lam LT, Fong DH, Lai SW, Tsoi HL, Tsui KL, Chui KL, Tam LW, Lee MK.   +26 more
europepmc   +1 more source

Invasive hemodynamic monitoring-guided resuscitation improves survival in shock: A systematic review and meta-analysis. [PDF]

Ann Intensive Care
Nagy L, Tóth PR, Turan C, Laczkó D, Légár L, Danisan B, Sipos Z, Hegyi P, Molnár Z, Zubek L.   +9 more
europepmc   +1 more source

Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report. [PDF]

Eur Heart J Case Rep
Lucas S, Hennart B, de Groote P, Lamblin N, Ridon H, Dupre C, Lionet A, Lemesle G.   +7 more
europepmc   +1 more source